الرئيسية
استكشاف
nav.journalClub
الرائج
المزيد
synapse
⌘+K
اللغة
العربية
العربية
CRISPR for next-generation point-of-care molecular diagnostics | Synapse
March 3, 2026
CRISPR for next-generation point-of-care molecular diagnostics
JF
Jinyu Fu
JY
Jiaming Yang
SS
Shuobo Shi
Beijing University of Chemical Technology
See all
Key Points
Point-of-care molecular diagnostics utilizing CRISPR show significant improvement in detection rates.
Aiming for faster, more accurate results, the study highlights CRISPR's utility in clinical settings with urgent needs.
Incorporating genetic engineering techniques, the approach may elevate existing diagnostic tools and capabilities.
These developments support further exploration of CRISPR in other applications beyond diagnostics to enhance healthcare outcomes.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Fu et al. (Sat,) studied this question.
synapsesocial.com/papers/69a75a0dc6e9836116a1f8ae
https://doi.org/https://doi.org/10.1016/j.microc.2026.117008
Mark Helpful
Like
Save
Bookmark
Relay
Share